HopeStage
Back to all studies
TerminatedNCT06462820

SAINT for MDD in an Inpatient Setting Follow-on

Device studyAges 18–75United StatesDepression
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.

Listed locations
Iowa City and 3 more locationsSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 30, 2024
Recruitment status
Terminated
Enrollment listed in the registry
2
Sponsor
Magnus Medical
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT06462820
Official title
Show the full official title

SAINT® Neuromodulation System for the Treatment of Depression in an Inpatient Setting

Recruitment & locations

Terminated

Iowa City · Manhattan · Charleston

1 more locations
  • Austin

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Magnus Medical.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies